ENHO and myocardial infarction: In this study, using an in vivo rat MI model, we demonstrated that the transplantation of adropin-treated MSCs into adropin-treated infarcted myocardium, an adropin-based dual protective strategy, may enhance the therapeutic potential of MSCs to improve cardiac function by promoting the survival of transplanted cells and modifying host microenvironment through paracrine mechanism.